Global Drug-Coated Balloons Market Trends and Growth Analysis 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Drug-Coated Balloons Market Expected To Expand Between 2025 And 2029?

The valuation of the drug-coated balloons sector has experienced swift escalation lately, projected to advance from a market worth 1.08 billion US dollars in 2024 to 1.24 billion US dollars in 2025, reflecting a compound annual growth rate approximating 14.6%. This expansion observed during the preceding period stems from several contributing factors, notably the rising incidence of cardiovascular ailments, a heightened need for less invasive surgical interventions, the widespread occurrence of peripheral artery disease (pad), successful efforts to lower rates of restenosis, and ongoing progress within the field of interventional cardiology.

Anticipation surrounds the drug-coated balloons sector, projecting substantial escalation in its valuation over the forthcoming years, reaching $2.2 billion by 2029, propelled by a compound annual growth rate (CAGR) of 15.5%. This considerable upswing anticipated during the projection timeframe is fundamentally driven by several factors, including the swelling demographic of elderly individuals, the broadening scope of available indications and applications, a strategic shift toward care delivery in outpatient settings and ambulatory centers, the incorporation of advancements in drug conveyance technologies, and various worldwide health campaigns. Key developments influencing this period are characterized by the securing of official clearances for novel product compositions, a concerted effort to reduce adverse effects, the advent of biodegradable surface treatments, market penetration into developing nations, and an increasing emphasis on methods tailored to individual patient needs.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

Which Major Market Drivers Are Shaping The Future Of The Drug-Coated Balloons Market?

Anticipated escalation in the occurrence of coronary artery disease is set to drive the expansion of the drug-coated balloons market in the future. Coronary artery disease (CAD), characterized by the constriction or blockage of the arteries supplying blood to the cardiac muscle, frequently results in myocardial infarction events. Drug-coated balloons represent a specific medical apparatus deployed in managing CAD; during the interventional process, medication is delivered directly into the vessel to mitigate the recurrence of artery narrowing post-angioplasty, known as restenosis. Evidence supporting this trend emerged in August 2022, when a publication in the Journal of the American College of Cardiology, originating from a US entity, projected that all four primary cardiovascular risk factors would increase among the overall American populace between 2025 and 2060; diabetes is projected to see the most substantial surge at 39.3%, succeeded by dyslipidemia at 27.6%, hypertension at 25.1%, and obesity recording an 18.3% rise. Furthermore, the investigators determined that the highest projected escalations in incidence rates belonged to heart failure (33.4%) and ischemic heart disease (30.7%), with heart attack (16.9%) and stroke (33.8%) also showing significant anticipated increases. Consequently, the growing incidence rate of coronary artery disease is projected to provide significant impetus to the market for drug-coated balloons.

What Are The Leading Segments Analyzed In The Drug-Coated Balloons Market?

The drug-coated balloonsmarket covered in this report is segmented –

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications

2) By Drug Type: Paclitaxel, Sirolimus

3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:

1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons

3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications

What Key Innovation Trends Are Fueling Advancements In The Drug-Coated Balloons Market?

A prominent trend in the market for drug-coated balloons involves a significant push toward product advancements, with key players actively channeling resources into pioneering technological and inventive remedies to solidify their standing. As an illustration of this focus, in August of 2022, the American medical technology firm Becton, Dickinson, and Company (BD) initiated the PREVISION first-in-human investigation concerning a peripheral sirolimus drug-coated balloon (DCB); the primary goal of this clinical study is to evaluate both the safety profile and the efficacy of the sirolimus DCB when administered to individuals afflicted by peripheral artery disease, a serious ailment that substantially compromises patients’ ability to move and their overall standard of living.

Which Major Industry Participants Are Leading The Drug-Coated Balloons Market Growth?

Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

Which Geographies Are Emerging As Strong Markets For The Drug-Coated Balloons Industry?

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Drug-Coated Balloons Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10829&type=smp

Browse Through More Reports Similar to the Global Drug-Coated Balloons Market 2025, By The Business Research Company

Pta Balloon Catheter Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-necrosis-factor-inhibitor-drugs-global-market-report

Antispasmodics Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antispasmodics-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795